MCTA

BEARISH

$29.36 Live

Charming Medical Limited · NASDAQ

$4.3 52W Range $31.7

MCTA Charming Medical Limited - Fundamental Analysis

BEARISH

Console Chart News

MCTA Stock | Fundamental Analysis & Investment Insights

NASDAQ • Healthcare • Medical Care Facilities

Current Price Live

$29.36

52W High

$31.7

52W Low

$4.3

Overview AI Snowflake Price Valuation Profitability Growth Health Statements Peers

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Apr 14, 2026

Market cap

$504.26M

P/E

419.36

ROE

N/A

Profit margin

12.1%

Debt/Equity

1.6

Dividend yield

N/A

AI Analysis

AI-powered fundamental assessment

Confidence

95%

MCTA exhibits a severe disconnect between its market price and fundamental value, with a Piotroski F-Score of 6/9 indicating stable internal health but failing to justify a valuation that dwarfs its Graham Number ($0.07) and Intrinsic Value ($0.49). The company is trading at an astronomical Price-to-Book ratio of 9785.00 and a P/E of 419.36 despite a significant revenue contraction of 27% YoY. While gross margins are exceptionally high, negative operating margins and a current ratio of 0.59 signal poor operational efficiency and liquidity risks. The technical trend is heavily bearish, suggesting a speculative bubble that is currently deflating.

Key Strengths

Stable Piotroski F-Score (6/9)

Exceptionally high gross margins (96.02%)

Positive net profit margin (12.12%)

Positive Return on Assets (10.64%)

Strong historical 1-year price appreciation

Key Risks

Extreme overvaluation (Price vs. Intrinsic Value)

Significant revenue decline (-27% YoY)

Severe liquidity risk (Current Ratio 0.59)

Negative operating margins (-0.94%)

Very bearish technical trend (10/100)

AI Fair Value Estimate

Based on comprehensive analysis

$0.49

-98.3% below current price

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall

Weak

Value

Future

Past

Health

Dividend

AI Verdict

Extreme Overvaluation

Key drivers: Price/Book ratio of 9785, Negative revenue growth, Massive gap between market price and intrinsic value

Confidence

95%

Value

0/100

The stock is trading at a massive premium to all deterministic value metrics.

Positives

No standout positives identified.

Watchpoints

P/E of 419.36
Price/Sales of 92.98
Graham Number of $0.07

Future

10/100

Negative growth makes the current valuation unsustainable.

Positives

No standout positives identified.

Watchpoints

Revenue growth is -27%
No forward P/E available

Past

40/100

Historical price action reflects speculation rather than organic growth.

Positives

Strong 1Y price performance (+319%)

Watchpoints

Price gains are not supported by fundamental growth

Health

50/100

Internal accounting health is stable, but liquidity is dangerously low.

Positives

Piotroski F-Score of 6/9

Watchpoints

Current Ratio 0.59
Debt/Equity 1.60

Dividend

0/100

No income component to the investment.

Positives

No standout positives identified.

Watchpoints

No dividend yield
0/100 dividend strength

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price

$29.36

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for MCTA and closest competitors.

Updated 2026-04-13

Company	5Y	3Y	1Y	6M	1M	1W
MCTA Charming Medical Limited Primary	+319.4%	+319.4%	+319.4%	+319.4%	0.0%	0.0%
IVVD Invivyd, Inc. Peer	-91.6%	+46.1%	+248.5%	0.0%	-7.4%	+37.5%
AVR Anteris Technologies Global Corp. Peer	-8.8%	-8.8%	+40.4%	+17.2%	-21.5%	-6.6%
ANGO AngioDynamics, Inc. Peer	-49.3%	+20.9%	+23.6%	+7.9%	+5.1%	+6.4%
KMDA Kamada Ltd. Peer	+49.5%	+95.6%	+48.0%	+28.6%	+2.3%	+0.2%

MCT

Charming Medical Limited

Primary

+319.4%

0.0%

IVV

Invivyd, Inc.

Peer

-91.6%

+46.1%

+248.5%

0.0%

-7.4%

+37.5%

AVR

Anteris Technologies Global Corp.

Peer

-8.8%

+40.4%

+17.2%

-21.5%

-6.6%

ANG

AngioDynamics, Inc.

Peer

-49.3%

+20.9%

+23.6%

+7.9%

+5.1%

+6.4%

KMD

Kamada Ltd.

Peer

+49.5%

+95.6%

+48.0%

+28.6%

+2.3%

+0.2%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

419.36

N/A

9785.0

92.98

82.63

388.4

$504.26M

Profitability

Profit margins and return metrics

Profit Margin 12.12%

Operating Margin -0.94%

Gross Margin 96.02%

ROE N/A

ROA 10.63%

Growth

Revenue and earnings growth rates

Revenue Growth -27.0%

Earnings Growth N/A

Q/Q Revenue Growth N/A

Q/Q Earnings Growth N/A

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity

1.6

High debt

Current Ratio

0.59

Weak

Quick Ratio

0.57

Poor

Cash/Share

$0.17

Financial Statement Flow

Interactive flow visualization showing how money moves through the company Q1 2025

Total Assets

$0.0B

Liabilities

$0.0B

Equity

$0.0B

Debt/Equity

107.76x

Healthcare Sector Comparison

Comparing MCTA against 319 companies in the Healthcare sector (20 bullish, 107 neutral, 192 bearish)

P/E Ratio

419.36

This Stock

88.11

Sector Avg

+375.9% (Expensive)

Profit Margin

12.12%

This Stock

-11.76%

Sector Avg

-203.1% (Weaker)

Debt to Equity

1.6

This Stock

3.51

Sector Avg

-54.3% (Less Debt)

Revenue Growth

-27.0%

This Stock

90.15%

Sector Avg

-129.9% (Slower)

Current Ratio

0.59

This Stock

3.67

Sector Avg

-84.0% (Weaker)

Similar Companies

Peer comparison within the same industry

Company	AI Rating	Market Cap	P/E	ROE	Profit Margin	Price
MCTA Charming Medical Limited	BEARISH	$504.26M	419.36	-%	12.1%	$29.36
IVVD Invivyd, Inc.	BEARISH	$497.73M	-	-34.0%	-98.2%	$1.76	Compare
AVR Anteris Technologies Global Corp.	BEARISH	$496.86M	-	-301.9%	-%	$5.11	Compare
ANGO AngioDynamics, Inc.	BEARISH	$492.14M	-	-15.3%	-9.0%	$11.94	Compare
KMDA Kamada Ltd.	NEUTRAL	$490.86M	24.26	7.6%	11.2%	$8.49	Compare

MCTA Charming Medical Limited

BEARISH

Mkt Cap

$504M

P/E

419.4

ROE

Price

$29.36

Compare with MCTA

Compare with MCTA

ANGO AngioDynamics, Inc.

Compare with MCTA

Compare with MCTA

Past News Coverage

Recent headlines mentioning MCTA from our newsroom.

Newest → oldest

Back to All Stocks

TradingGPT V2 Copilot

Fundamentals • Valuation • Risk

Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends

MCTA

MCTA Charming Medical Limited - Fundamental Analysis

At a glance

AI Analysis

Key Strengths

Key Risks

Performance Snowflake

Stock Price & Analyst Targets

Multi-Horizon Performance vs Peers

Historical Performance Trends

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Valuation Metrics

Profitability

Growth

Financial Health

Financial Statement Flow

Healthcare Sector Comparison

Similar Companies

Past News Coverage

Wait — Don't Miss Out!